Skip Navigation

A PHASE 2 RANDOMIZED TRIAL OF CALORIC RESTRICTION AND ACTIVITY TO REDUCE CHEMORESISTANCE IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA IDEAL2

Brief Summary

Type:
Leukemias

Study Type:
Supportive Care

Phase:
II

ClinicalTrials.gov Identifier:
NCT05082519

Study #:
CMH - T2020-003

Start Date:
Feb 04, 2025

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT05082519

View Complete Trial Details & Eligibility at ClinicalTrials.gov